Home » Topics » BioWorld Science

BioWorld Science
RSS

rhIL-11 effective in rats with adjuvant arthritis

Nov. 19, 1997

Basiliximab reduces renal allograft rejection in phase III trial

Nov. 19, 1997

Scripps prepares MCBI analogues of antitumor antibiotics

Nov. 19, 1997

rhIL-10 evaluated for safety and efficacy in RA patients

Nov. 19, 1997

Complement activation inhibitors prepared at U of Pennsylvania

Nov. 19, 1997

Cell Genesys issued U.S. patent for gene therapy

Nov. 19, 1997

Rogaine Extra Strength approved by FDA as OTC

Nov. 19, 1997

New cardiotonic agent reported by Japanese academics

Nov. 19, 1997

MiKasome enters phase II for UTI

Nov. 18, 1997

U.S. patent coverage for Verex's controlled-release AZT product

Nov. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...